Company Comparison
Nurix Therapeutics vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Nurix Therapeutics | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | Lagos, Nigeria |
| Founded | — | 2019 |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | — | $45M |
| Valuation | — | — |
What They Build
Nurix Therapeutics
A clinical-stage biopharmaceutical company developing precision medicines using targeted protein degradation technology for cancer and inflammatory diseases.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Nurix Therapeutics
Sector Overlap
Both Nurix Therapeutics and 54gene operate in Biotech.
Browse all Biotech companies →